Evidence map›Paper›PMID 40982710›Full record

ArticleExperimental physiology2025

Effects of tempol on renal medullary tissue hypoxia in an ovine model of Gram-negative septic acute kidney injury.

Rachel Peiris, Anton Trask-Marino, Alemayehu Jufar, Ashenafi H Betrie, Adam Southon, Sally G Hood, Rinaldo Bellomo, Abraham H Hulst, Clive N May, Connie P C Ow and 1 more

Abstract read
In one paragraph

Article in Experimental physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel PeirisPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Anton Trask-MarinoPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-4058-8905
Alemayehu JufarPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Ashenafi H BetriePreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Adam SouthonTranslational Neurodegeneration Laboratory, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Sally G HoodPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Rinaldo BellomoDepartment of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Abraham H HulstPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Clive N MayPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
Connie P C OwPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-5402-1809
Yugeesh R LankadevaPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.

Funding

Jack Brockhoff Foundation (JBF) JBF4178National Health and Medical Research Council (NHMRC)>National Health and Medical Research Council (NHMRC) GNT1188514National Heart Foundation of Australia (Heart Foundation)>National Heart Foundation of Australia (Heart Foundation) FLF105666
6 · The paper itself

Abstract

Renal arterial infusion of tempol (RAT) at the onset of Gram-negative sepsis can prevent sepsis-induced medullary tissue hypoxia and acute kidney injury (AKI). However, it is not known whether treatment with tempol at a clinically relevant time point of sepsis is similarly effective. Thus, we examined whether tempol can reverse renal medullary tissue hypoxia after ovine Gram-negative septic AKI. Following right unilateral nephrectomy, the left kidney was instrumented with a renal arterial catheter and oxygen-sensing fibre-optic probes into the renal medulla. After 23 h of Escherichia coli infusion, conscious sheep were fluid resuscitated with Hartmann's solution (30 mL/kg over 0.5 h) and randomized to intravenous tempol (IVT; n = 7) at 30 mg/kg/h, RAT (3 mg/kg/h; n = 6) or vehicle (n = 5) from 24 to 31 h of sepsis. At 31 h, E. coli infusion ceased, and sheep received ceftriaxone (1 g) and were allowed a 48 h recovery period. At 23 h of E. coli infusion, septic sheep developed a 2.2 ± 0.8-fold increase in plasma creatinine and a 57% ± 6% decrease in urine output, and the renal medulla was ischaemic and hypoxic. Neither RAT nor IVT attenuated the sepsis-induced renal medullary tissue hypoxia during the 7 h intervention period. Renal medullary tissue partial pressure of O

Indexed as

acute kidney injuryhypoxiaoxidative stressrenal microcirculationsepsistempol

Identifiers

PMID40982710
PMCPMC13394757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.